Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study

3 min

Background

One of the problems with prostate-specific antigen (PSA) testing for prostate cancer is that of over-treatment, that is, diagnosing and treating cancers (with potentially serious side-effects) that are not likely to ever cause symptoms or shorten life.

This is of particular relevance to older men with life expectancies of 10-20 years who may not benefit from having prostate cancers detected at this stage of their lives.

Aim

To determine the relationship between concentrations of PSA at age 60 and subsequent diagnosis of clinically relevant prostate cancer in an unscreened population, to evaluate whether screening for prostate cancer and chemoprevention could be stratified by risk.

Methods

Results

The rate of screening during the course of the study was low and no cancers were detected by screening. There were 43 cases of metastasis and 35 deaths from prostate cancer.

Concentration of prostate specific antigen at age 60 was associated with prostate cancer metastasis (area under the curve 0.86, 95% confidence interval 0.79 to 0.92; P<0.001) and death from prostate cancer (0.90, 0.84 to 0.96; P<0.001).

The greater the number for the area under the curve (values from 0 to 1) the better the test.

Although only a minority of the men with concentrations in the top quartile (>2 ng/ml) develop fatal prostate cancer, 90% (78% to 100%) of deaths from prostate cancer occurred in these men.

Conversely, men aged 60 with concentrations at the median or lower (</=1 ng/ml) were unlikely to have clinically relevant prostate cancer (0.5% risk of metastasis by age 85 and 0.2% risk of death from prostate cancer).

Conclusion

The concentration of prostate specific antigen at age 60 predicts lifetime risk of metastasis and death from prostate cancer.

Though men aged 60 with concentrations below the median (</=1 ng/ml) might harbour prostate cancer, it is unlikely to become life threatening. Such men could be exempted from further screening, which should instead focus on men with higher concentrations.

More for health practitioners

We offer a range of evidence-based resources for health practitioners to develop their understanding of male health.


Did you find this page helpful?

Information provided on this website is not a substitute for medical advice

Call 000 for emergency services

If you or someone you know needs urgent medical attention.

Call MensLine Australia on 1300 78 99 78 for 24/7 support

MensLine Australia is a telephone and online counselling service for men with emotional health and relationship concerns.

Sign up to our newsletter

We release two monthly newsletters – one written for men, family and friends, and another for health practitioners.

Your preferred mailing list

Your name

Your email

Stay up to date

FacebookInstagramLinkedinTwitterYoutubespotifytiktok

Healthy Male acknowledges the traditional owners of the land. We pay our respects to elders past, present and future. We are committed to providing respectful, inclusive services and work environments where all individuals feel accepted, safe, affirmed and celebrated. Aboriginal and Torres Strait Islander people should be aware that this website may contain images, voices and names of deceased persons.

Disclaimer

Healthy Male is funded by the Australian Government Department of Health and Aged Care. This website does not host any form of advertisement. Information provided on this website is not a substitute for medical advice.

Trusted information partner of